Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 5
1965 4
1966 1
1967 1
1968 1
1969 4
1970 6
1971 10
1972 6
1973 162
1974 464
1975 511
1976 559
1977 497
1978 532
1979 539
1980 558
1981 566
1982 582
1983 591
1984 708
1985 758
1986 799
1987 793
1988 779
1989 869
1990 998
1991 982
1992 990
1993 1019
1994 1020
1995 935
1996 899
1997 828
1998 889
1999 809
2000 955
2001 892
2002 888
2003 882
2004 896
2005 1008
2006 1010
2007 951
2008 1022
2009 1065
2010 1056
2011 986
2012 1033
2013 1080
2014 1029
2015 1081
2016 1011
2017 1048
2018 985
2019 953
2020 1077
2021 1083
2022 1108
2023 1019
2024 910
2025 997
2026 484

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43,003 results

Results by year

Filters applied: . Clear all
Page 1
Ganirelix.
Gillies PS, Faulds D, Balfour JA, Perry CM. Gillies PS, et al. Drugs. 2000 Jan;59(1):107-11; discussion 112-3. doi: 10.2165/00003495-200059010-00007. Drugs. 2000. PMID: 10718102 Review.
Ganirelix is a synthetic third generation gonadotropin-releasing hormone (GnRH) antagonist that is administered via the subcutaneous route. The drug competitively blocks GnRH receptors in the anterior pituitary gland, preventing endogenous GnRH from inducing …
Ganirelix is a synthetic third generation gonadotropin-releasing hormone (GnRH) antagonist that is administered via the …
Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin.
Torrini F, Scarano S, Palladino P, Minunni M. Torrini F, et al. J Pharm Biomed Anal. 2023 May 10;228:115312. doi: 10.1016/j.jpba.2023.115312. Epub 2023 Feb 23. J Pharm Biomed Anal. 2023. PMID: 36858006 Free article. Review.
Specifically, as a paradigmatic example, we report the case of gonadorelin, a neuropeptide that in recent years has drawn a lot of attention as a therapeutic drug misused in doping practices during sports competitions....
Specifically, as a paradigmatic example, we report the case of gonadorelin, a neuropeptide that in recent years has drawn a lot of at …
Gonadorelin and erythropoiesis.
Hashimoto T, Miyai K. Hashimoto T, et al. Arch Intern Med. 1981 Feb;141(2):267. Arch Intern Med. 1981. PMID: 7006547 No abstract available.
Gonadorelin--synthetic LH-RH.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1983 Nov 25;25(649):106-7. Med Lett Drugs Ther. 1983. PMID: 6358816 No abstract available.
The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men.
Zhang L, Cai K, Wang Y, Ji W, Cheng Z, Chen G, Liao Z. Zhang L, et al. Am J Mens Health. 2019 Jan-Feb;13(1):1557988318818280. doi: 10.1177/1557988318818280. Epub 2018 Dec 20. Am J Mens Health. 2019. PMID: 30569789 Free PMC article.
The objective of this study was to compare the effect of pulsatile gonadorelin pump (PGP) and cyclical gonadotropin (human chorionic gonadotropin [HCG]/human menopausal gonadotropin [HMG]) therapy (CGT) on spermatogenesis in congenital hypogonadotropic hypogonadism (CHH) m …
The objective of this study was to compare the effect of pulsatile gonadorelin pump (PGP) and cyclical gonadotropin (human chorionic …
Effect of 200 mug of gonadorelin hydrochloride at the first GnRH of a CO-Synch program on ovulation rate and pregnancies per artificial insemination in Holstein heifers.
Melo DB, Coelho WM Jr, Marques TC, Salman S, Macedo IM, Castro T, Menezes MCG, Monteiro HF, Cotterman RF, Conley AJ, Lima FS. Melo DB, et al. J Dairy Sci. 2024 Aug;107(8):6268-6277. doi: 10.3168/jds.2023-24246. Epub 2024 Mar 8. J Dairy Sci. 2024. PMID: 38460874 Free article.
The objective of this study was to determine the effect of the highest label dose 200 mug (100 mug vs. 200 mug) of GnRH (50 mug of gonadorelin hydrochloride per mL; Factrel, Zoetis Inc. Madison, NJ) at the first GnRH of a 6-d CO-Synch plus P4 device program on ovulatory re …
The objective of this study was to determine the effect of the highest label dose 200 mug (100 mug vs. 200 mug) of GnRH (50 mug of gonado …
Reproductive performance of goats treated with free gonadorelin or nanoconjugated gonadorelin at estrus.
Hashem NM, Sallam SM. Hashem NM, et al. Domest Anim Endocrinol. 2020 Apr;71:106390. doi: 10.1016/j.domaniend.2019.106390. Epub 2019 Sep 6. Domest Anim Endocrinol. 2020. PMID: 31731249
The reproductive performance of goats that received a GnRH analog (gonadorelin) fabricated with or without chitosan-sodium tripolyphosphate (TPP) nanoparticles on the day of estrus (day 0) was evaluated. ...Goats showing signs of estrus were divided equally into 3 experime …
The reproductive performance of goats that received a GnRH analog (gonadorelin) fabricated with or without chitosan-sodium tripolypho …
GnRH antagonists.
Devroey P. Devroey P. Fertil Steril. 2000 Jan;73(1):15-7. doi: 10.1016/s0015-0282(99)00448-3. Fertil Steril. 2000. PMID: 10632404 Free article. No abstract available.
43,003 results
You have reached the last available page of results. Please see the User Guide for more information.